2'-cyano-2'-deoxyarabinofuranosylcytosine and dacarbazine

2'-cyano-2'-deoxyarabinofuranosylcytosine has been researched along with dacarbazine in 1 studies

Compound Research Comparison

Studies (2'-cyano-2'-deoxyarabinofuranosylcytosine)	Trials (2'-cyano-2'-deoxyarabinofuranosylcytosine)	Recent Studies (post-2010) (2'-cyano-2'-deoxyarabinofuranosylcytosine)	Studies (dacarbazine)	Trials (dacarbazine)	Recent Studies (post-2010) (dacarbazine)
31	0	6	7,556	1,463	3,429

Protein Interaction Comparison

Protein	Taxonomy	2'-cyano-2'-deoxyarabinofuranosylcytosine (IC50)	dacarbazine (IC50)
Matrix metalloproteinase-9	Homo sapiens (human)		0.556

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hargis, S; Jiang, Y; Liu, X; Nowak, B; Plunkett, W	1

Other Studies

1 other study(ies) available for 2'-cyano-2'-deoxyarabinofuranosylcytosine and dacarbazine

Article	Year
Mechanism-Based Drug Combinations with the DNA Strand-Breaking Nucleoside Analog CNDAC. Molecular cancer therapeutics, 2016, Volume: 15, Issue:10 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cricetinae; Cytarabine; Dacarbazine; DNA Breaks; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Homologous Recombination; Humans; Platinum; Poly (ADP-Ribose) Polymerase-1; Temozolomide; Tumor Suppressor Protein p53	2016

Article

Year

Mechanism-Based Drug Combinations with the DNA Strand-Breaking Nucleoside Analog CNDAC.

Molecular cancer therapeutics, 2016, Volume: 15, Issue:10

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cricetinae; Cytarabine; Dacarbazine; DNA Breaks; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Homologous Recombination; Humans; Platinum; Poly (ADP-Ribose) Polymerase-1; Temozolomide; Tumor Suppressor Protein p53

2016